The DOI matches its Crossref record; 107 of the 107 references it cites were found in a registry or an index.
Aspirin
Abstract
alicylates, in the form of willow bark, were used as an analgesic during the time of Hippocrates, and their antipyretic effects have been recognized for more than 200 years. 1Acetylsalicylic acid, or aspirin, was introduced in the late 1890s 2 and has been used to treat a variety of inflammatory conditions; however, the antiplatelet activity of this agent was not recognized until almost 70 years later. 3Recent advances in our understanding of the central role of platelets in the pathophysiology of cardiovascular disease have spurred in-depth investigations into the mechanisms of action of aspirin and the clinical utility of this agent in the treatment of common cardiovascular disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1996) · The Lancet · doi:10.1016/s0140-6736(96)09457-3 · Cited by 6,503
Hansson, L., Zanchetti, A., Carruthers, S. G., Dahlöf, B., Elmfeldt, D., Julius, S., Ménard, J., Rahn, K. H., Wedel, H., & Westerling, S. (1998) · The Lancet · doi:10.1016/s0140-6736(98)04311-6 · Cited by 5,728
Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men
Ridker, P. M., Cushman, M., Stampfer, M. J., Tracy, R. P., & Hennekens, C. H. (1997) · New England Journal of Medicine · doi:10.1056/nejm199704033361401 · Cited by 5,504
Serruys, P. W., de Jaegere, P., Kiemeneij, F., Macaya, C., Rutsch, W., Heyndrickx, G., Emanuelsson, H., Marco, J., Legrand, V., Materne, P., et al. (1994) · New England Journal of Medicine · doi:10.1056/nejm199408253310801 · Cited by 4,556
(1993) · New England Journal of Medicine · doi:10.1056/nejm199309023291001 · Cited by 4,055
Antiplatelet Trialists' Collaboration (1994) · BMJ · doi:10.1136/bmj.308.6921.81 · Cited by 3,126
Fibrinolytic Therapy Trialists' (FTT) Collaborative Group (1994) · The Lancet · doi:10.1016/s0140-6736(94)91161-4 · Cited by 2,744
Vane, J. R., Bakhle, Y. S., & Botting, R. M. (1998) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.38.1.97 · Cited by 2,734
(1994) · New England Journal of Medicine · doi:10.1056/nejm199404073301402 · Cited by 2,589
Final Report on the Aspirin Component of the Ongoing Physicians' Health Study
Steering Committee of the Physicians' Health Study Research Group* (1989) · New England Journal of Medicine · doi:10.1056/nejm198907203210301 · Cited by 2,264
(1997) · New England Journal of Medicine · doi:10.1056/nejm199706123362401 · Cited by 1,883
Petersen, P., Godtfredsen, J., Boysen, G., Andersen, E., & Andersen, B. (1989) · The Lancet · doi:10.1016/s0140-6736(89)91200-2 · Cited by 1,820
A Clinical Trial Comparing Three Antithrombotic-Drug Regimens after Coronary-Artery Stenting
Leon, M. B., Baim, D. S., Popma, J. J., Gordon, P. C., Cutlip, D. E., Ho, K. K. L., Giambartolomei, A., Diver, D. J., Lasorda, D. M., Williams, D. O., et al. (1998) · New England Journal of Medicine · doi:10.1056/nejm199812033392303 · Cited by 1,815
Kujubu, D. A., Fletcher, B. S., Varnum, B. C., Lim, R. W., & Herschman, H. R. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)98774-0 · Cited by 1,789
EAFT (European Atrial Fibrillation Trial) Study Group (1993) · The Lancet · doi:10.1016/0140-6736(93)92358-z · Cited by 1,741
Lewis, H. D., Davis, J. W., Archibald, D. G., Steinke, W. E., Smitherman, T. C., Doherty, J. E., Schnaper, H. W., LeWinter, M. M., Linares, E., Pouget, J. M., et al. (1983) · New England Journal of Medicine · doi:10.1056/nejm198308183090703 · Cited by 1,709
Xie, W. L., Chipman, J. G., Robertson, D. L., Erikson, R. L., & Simmons, D. L. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.7.2692 · Cited by 1,707
Diener, H. C., Cunha, L., Forbes, C., Sivenius, J., Smets, P., & Lowenthal, A. (1996) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(96)00308-5 · Cited by 1,577
(1998) · New England Journal of Medicine · doi:10.1056/nejm199805213382102 · Cited by 1,321
Aspirin, Heparin, or Both to Treat Acute Unstable Angina
Théroux, P., Ouimet, H., McCans, J., Latour, J.-G., Joly, P., Lévy, G., Pelletier, E., Juneau, M., Stasiak, J., deGuise, P., et al. (1988) · New England Journal of Medicine · doi:10.1056/nejm198810273191701 · Cited by 1,276
Meade, E. A., Smith, W. L., & DeWitt, D. L. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)53294-4 · Cited by 1,256
Chen, Z.-M. (1997) · The Lancet · doi:10.1016/s0140-6736(97)04010-5 · Cited by 1,232
The United Kingdom transient ischaemic attack (UK-TIA) aspirin trial: final results.
Farrell, B., Godwin, J., Richards, S., & Warlow, C. (1991) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.54.12.1044 · Cited by 1,203
Hass, W. K., Easton, J. D., Adams, H. P., Pryse-Phillips, W., Molony, B. A., Anderson, S., Kamm, B., & for the Ticlopidine Aspirin Stroke Study Group (1989) · New England Journal of Medicine · doi:10.1056/nejm198908243210804 · Cited by 1,198
Hawkey, C. (1999) · The Lancet · doi:10.1016/s0140-6736(98)12154-2 · Cited by 1,173
Aspirin, Sulfinpyrazone, or Both in Unstable Angina: Results of a Canadian Multicenter Trial
Cairns, J. A., Gent, M., Singer, J., Finnie, K. J., Froggatt, G. M., Holder, D. A., Jablonsky, G., Kostuk, W. J., Melendez, L. J., Myers, M. G., et al. (1985) · New England Journal of Medicine · doi:10.1056/nejm198511283132201 · Cited by 1,120
Topol, E. J. (1998) · The Lancet · doi:10.1016/s0140-6736(98)85010-1 · Cited by 1,095
Patrignani, P., Filabozzi, P., & Patrono, C. (1982) · Journal of Clinical Investigation · doi:10.1172/jci110576 · Cited by 937
THE CANADIAN AMERICAN TICLOPIDINE STUDY (CATS) IN THROMBOEMBOLIC STROKE
Gent, M., Donald Easton, J., Hachinski, V., Panak, E., Sicurella, J., Blakely, J., Ellis, D., Harbison, J., Roberts, R., & Turpie, A. G. (1989) · The Lancet · doi:10.1016/s0140-6736(89)92327-1 · Cited by 910
Roth, G. J., & Majerus, P. W. (1975) · Journal of Clinical Investigation · doi:10.1172/jci108132 · Cited by 861
Intolerance to Aspirin: Clinical Studies and Consideration of its Pathogenesis
SAMTER, M., & BEERS, R. F. (1968) · Annals of Internal Medicine · doi:10.7326/0003-4819-68-5-975 · Cited by 839
A Comparison of Aspirin plus Tirofiban with Aspirin plus Heparin for Unstable Angina
(1998) · New England Journal of Medicine · doi:10.1056/nejm199805213382103 · Cited by 796
The RISC Group (1990) · The Lancet · doi:10.1016/0140-6736(90)92336-g · Cited by 781
(1991) · New England Journal of Medicine · doi:10.1056/nejm199110313251801 · Cited by 759
Hamm, C. W., Heeschen, C., Goldmann, B., Vahanian, A., Adgey, J., Miguel, C. M., Rutsch, W., Berger, J., Kootstra, J., & Simoons, M. L. (1999) · New England Journal of Medicine · doi:10.1056/nejm199905273402103 · Cited by 710
Schwartz, L., Bourassa, M. G., Lespérance, J., Aldridge, H. E., Kazim, F., Salvatori, V. A., Henderson, M., Bonan, R., & David, P. R. (1988) · New England Journal of Medicine · doi:10.1056/nejm198806303182603 · Cited by 692
FitzGerald, G. A., Oates, J. A., Hawiger, J., Maas, R. L., Roberts, L. J., Lawson, J. A., & Brash, A. R. (1983) · Journal of Clinical Investigation · doi:10.1172/jci110814 · Cited by 665
Different Intracellular Locations for Prostaglandin Endoperoxide H Synthase-1 and −2
Morita, I., Schindler, M., Regier, M. K., Otto, J. C., Hori, T., DeWitt, D. L., & Smith, W. L. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.18.10902 · Cited by 572
Dose-Related Kinetics of Aspirin: Presystemic Acetylation of Platelet Cyclooxygenase
Pedersen, A. K., & FitzGerald, G. A. (1984) · New England Journal of Medicine · doi:10.1056/nejm198411083111902 · Cited by 558
The Salt Collaborative Group (1991) · The Lancet · doi:10.1016/0140-6736(91)92233-r · Cited by 553
Taylor, D. W., Barnett, H. J., Haynes, R. B., Ferguson, G. G., Sackett, D. L., Thorpe, K. E., Simard, D., Silver, F. L., Hachinski, V., Clagett, G. P., et al. (1999) · The Lancet · doi:10.1016/s0140-6736(99)05388-x · Cited by 530
Aspirin and Risk of Hemorrhagic Stroke: A Meta-analysis of Randomized Controlled Trials
He, J., Whelton, P. K., Vu, B., & Klag, M. J. (1998) · JAMA · doi:10.1001/jama.280.22.1930 · Cited by 521
Elwood, P. C., Cochrane, A., Burr, M. L., Sweetnam, P. M., Williams, G., Welsby, E., Hughes, S. J., & Renton, R. (1974) · BMJ · doi:10.1136/bmj.1.5905.436 · Cited by 519
JUULMOLLER, S. (1992) · The Lancet · doi:10.1016/0140-6736(92)92619-q · Cited by 517
Loll, P. J., Picot, D., & Garavito, R. M. (1995) · Nature Structural Biology · doi:10.1038/nsb0895-637 · Cited by 490
Reactivation of Unstable Angina after the Discontinuation of Heparin
Théroux, P., Waters, D., Lam, J., Juneau, M., & McCans, J. (1992) · New England Journal of Medicine · doi:10.1056/nejm199207163270301 · Cited by 464
Weksler, B. B., Pett, S. B., Alonso, D., Richter, R. C., Stelzer, P., Subramanian, V., Tack-Goldman, K., & Gay, W. A. (1983) · New England Journal of Medicine · doi:10.1056/nejm198304073081402 · Cited by 448
Hsia, J., Hamilton, W. P., Kleiman, N., Roberts, R., Chaitman, B. R., & Ross, A. M. (1990) · New England Journal of Medicine · doi:10.1056/nejm199011223232101 · Cited by 422
Kelly, J. P., Kaufman, D. W., Jurgelon, J. M., Sheehan, J., Koff, R. S., & Shapiro, S. (1996) · The Lancet · doi:10.1016/s0140-6736(96)01254-8 · Cited by 418
Gierse, J. K., McDonald, J. J., Hauser, S. D., Rangwala, S. H., Koboldt, C. M., & Seibert, K. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.26.15810 · Cited by 410
Oates, J. A., Wood, A. J. J., & FitzGerald, G. A. (1987) · New England Journal of Medicine · doi:10.1056/nejm198705143162005 · Cited by 408
Baigent, C., Collins, R., Appleby, P., Parish, S., Sleight, P., & Peto, R. (1998) · BMJ · doi:10.1136/bmj.316.7141.1337 · Cited by 404
United Kingdom transient ischaemic attack (UK-TIA) aspirin trial: interim results
Uk-Tia Study Group (1988) · BMJ · doi:10.1136/bmj.296.6618.316 · Cited by 388
IMPAIRED PLATELET/CONNECTIVE-TISSUE REACTION IN MAN AFTER ASPIRIN INGESTION
Weiss, H., & Aledort, L. (1967) · The Lancet · doi:10.1016/s0140-6736(67)91658-3 · Cited by 379
ASPIRIN AND SECONDARY MORTALITY AFTER MYOCARDIAL INFARCTION
Elwood, P. C., & Sweetnam, P. M. (1979) · The Lancet · doi:10.1016/s0140-6736(79)92808-3 · Cited by 360
Suppression of Thromboxane A2but Not of Systemic Prostacyclin by Controlled-Release Aspirin
Clarke, R. J., Mayo, G., Price, P., & FitzGerald, G. A. (1991) · New England Journal of Medicine · doi:10.1056/nejm199110173251605 · Cited by 346
The Antiplatelet Effects of Ticlopidine and Clopidogrel
Sharis, P. J., Cannon, C. P., & Loscalzo, J. (1998) · Annals of Internal Medicine · doi:10.7326/0003-4819-129-5-199809010-00009 · Cited by 322
Self-citationAspirin in coronary heart disease
(1976) · Journal of Chronic Diseases · doi:10.1016/0021-9681(76)90020-5 · Cited by 309
Bowker, T. J., Clayton, T. C., Ingham, J., McLennan, N. R., Hobson, H. L., Pyke, S. D., Schofield, B., & Wood, D. A. (1996) · Heart · doi:10.1136/hrt.75.4.334 · Cited by 305
Gulløv, A. L., Koefoed, B. G., Petersen, P., Pedersen, T. S., Andersen, E. D., Godtfredsen, J., & Boysen, G. (1998) · Archives of Internal Medicine · doi:10.1001/archinte.158.14.1513 · Cited by 301
The clinical significance of inhibition of renal prostaglandin synthesis
Patrono, C., & Dunn, M. J. (1987) · Kidney International · doi:10.1038/ki.1987.164 · Cited by 296
Antithrombotic Therapy in Atrial Fibrillation
Laupacis, A., Albers, G., Dalen, J., Dunn, M. I., Jacobson, A. K., & Singer, D. E. (1998) · Chest · doi:10.1378/chest.114.5_supplement.579s · Cited by 294
The gastrointestinal toxicity of aspirin: an overview of randomised controlled trials.
Roderick, P., Wilkes, H., & Meade, T. (1993) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1993.tb05689.x · Cited by 293
A Prospective Study of Aspirin Use and Primary Prevention of Cardiovascular Disease in Women
Manson, J. E. (1991) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1991.03470040085027 · Cited by 272
Al-Khadra, A. S., Salem, D. N., Rand, W. M., Udelson, J. E., Smith, J. J., & Konstam, M. A. (1998) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(97)00502-0 · Cited by 270
Aspirin-like Molecules that Covalently Inactivate Cyclooxygenase-2
Kalgutkar, A. S., Crews, B. C., Rowlinson, S. W., Garner, C., Seibert, K., & Marnett, L. J. (1998) · Science · doi:10.1126/science.280.5367.1268 · Cited by 258
Counteraction of the vasodilator effects of enalapril by aspirin in severe heart failure
Hall, D., Zeitler, H., & Rudolph, W. (1992) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(92)90449-w · Cited by 237
PGH synthase isoenzyme selectivity: The potential for safer nonsteroidal antiinflammatory drugs
DeWitt, D. L., Meade, E. A., & Smith, W. L. (1993) · The American Journal of Medicine · doi:10.1016/0002-9343(93)90396-7 · Cited by 222
Low-Dose Aspirin Therapy for Chronic Stable Angina: A Randomized, Placebo-Controlled Clinical Trial
Ridker, P. M., Manson, J. E., Gaziano, J. M., Buring, J. E., & Hennekens, C. H. (1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-114-10-835 · Cited by 221
Nonsteroidal Anti-inflammatory Drugs and the Risk for Chronic Renal Disease
Sandler, D. P., Burr, F. R., & Weinberg, C. R. (1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-115-3-165 · Cited by 213
Patrono, C., Coller, B., Dalen, J. E., Fuster, V., Gent, M., Harker, L. A., Hirsh, J., & Roth, G. (1998) · Chest · doi:10.1378/chest.114.5_supplement.470s · Cited by 190
Cyclooxygenase-2 in human platelets as a possible factor in aspirin resistance
Weber, A.-A., Zimmermann, K. C., Meyer-Kirchrath, J., & Schrör, K. (1999) · The Lancet · doi:10.1016/s0140-6736(99)00498-5 · Cited by 188
In vitro Acetylation of Plasma Proteins, Enzymes and DNA by Aspirin
Pinckard, R. N., Hawkins, D., & Farr, R. S. (1968) · Nature · doi:10.1038/219068a0 · Cited by 187
Roux, S., Christeller, S., & Lüdin, E. (1992) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(10)80290-6 · Cited by 184
Pharmakologisches über Aspirin (Acetylsalicylsäure)
Dreser, H. (1899) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/bf01662127 · Cited by 181
Wallentin, L. C. (1991) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(91)90489-v · Cited by 171
Neri Serneri, G. G., Gensini, G. F., Poggesi, L., Trotta, F., Modesti, P. A., Boddi, M., Ieri, A., Margheri, M., Casolo, G. C., Bini, M., et al. (1990) · The Lancet · doi:10.1016/0140-6736(90)90407-v · Cited by 170
Côté, R., Battista, R. N., Abrahamowicz, M., Langlois, Y., Bourque, F., Mackey, A., & and The Asymptomatic Cervical Bruit Study Group* (1995) · Annals of Internal Medicine · doi:10.7326/0003-4819-123-9-199511010-00002 · Cited by 169
Anti-thrombotic effects of a nitric oxide-releasing, gastric-sparing aspirin derivative.
Wallace, J. L., McKnight, W., Soldato, P. D., Baydoun, A. R., & Cirino, G. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118338 · Cited by 161
Bjornsson, T. D., Schneider, D., & Berger, H. (1989) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)21331-3 · Cited by 139
Salicylate hydroxylation as an early marker of in vivo oxidative stress in diabetic patients
Ghiselli, A., Laurenti, O., MATTIA, G. D., Maiani, G., & Ferro-Luzzi, A. (1992) · Free Radical Biology and Medicine · doi:10.1016/0891-5849(92)90036-g · Cited by 138
Stone, E. (1763) · Philosophical Transactions of the Royal Society of London · doi:10.1098/rstl.1763.0033 · Cited by 135
An Overview of the British and American Aspirin Studies
Hennekens, C. H., Peto, R., Hutchison, G. B., & Doll, R. (1988) · New England Journal of Medicine · doi:10.1056/nejm198804073181412 · Cited by 115
Antithrombotic Therapy in Patients With Saphenous Vein and Internal Mammary Artery Bypass Grafts
Stein, P. D., Dalen, J. E., Goldman, S., & Théroux, P. (1998) · CHEST Journal · doi:10.1378/chest.114.5_supplement.658s · Cited by 112
Prognosis of asymptomatic or mildly symptomatic patients with coronary artery disease
Kent, K. M., Rosing, D. R., Ewels, C. J., et al. (1982) · The American Journal of Cardiology · doi:10.1016/0002-9149(82)90198-9 · Cited by 107
Rapidity and duration of platelet suppression by enteric-coated aspirin in healthy young men
Jimenez, A. H., Stubbs, M. E., Tofler, G. H., Winther, K., Williams, G. H., & Muller, J. E. (1992) · The American Journal of Cardiology · doi:10.1016/0002-9149(92)91316-v · Cited by 89
Prothrombotic Consequences of the Oxidation of Fibrinogen and their Inhibition by Aspirin
Upchurch, G. R., Ramdev, N., Walsh, M. T., & Loscalzo, J. (1998) · Journal of Thrombosis and Thrombolysis · doi:10.1023/a:1008859729045 · Cited by 88
Self-citationUkawa, H., Yamakuni, H., Kato, S., & Takeuchi, K. (1998) · Digestive Diseases and Sciences · doi:10.1023/a:1018846912032 · Cited by 85
Patterns of aspirin use in middle-aged adults: The atherosclerosis risk in communities (ARIC) study
Shahar, E., Folsom, A. R., Romm, F. J., Bisgard, K. M., Metcalf, P., Crum, L. D., McGovern, P. G., Hutchinson, R. G., & HEISS, G. M. (1996) · American Heart Journal · doi:10.1016/s0002-8703(96)90173-8 · Cited by 81
Aspirin protects low density lipoprotein from oxidative modification.
Steer, K. A., Wallace, T. M., Bolton, C., & Hartog, M. (1997) · Heart · doi:10.1136/hrt.77.4.333 · Cited by 79
Takeuchi, K., Ukawa, H., Konaka, A., Kitamura, M., & Sugawa, Y. (1998) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37564-0 · Cited by 74
Human globin gene analysis for a patient with beta-o/delta beta-thalassemia.
Ottolenghi, S., Lanyon, W. G., Williamson, R., Weatherall, D. J., Clegg, J. B., & Pitcher, C. S. (1975) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.72.6.2294 · Cited by 69
Farivar, R. S., & Brecher, P. I. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.49.31585 · Cited by 69
Nyman, I., Larsson, H. B. W., & Wallentin, L. C. (1992) · The Lancet · doi:10.1016/0140-6736(92)91706-e · Cited by 67
Betts, W. H., Whitehouse, M. W., Cleland, L. G., & Vernon-Roberts, B. (1985) · Journal of Free Radicals in Biology & Medicine · doi:10.1016/0748-5514(85)90131-x · Cited by 61
Mechanism of Aspirin Sensitivity
Lee, T. H. (1992) · American Review of Respiratory Disease · doi:10.1164/ajrccm/145.2_pt_2.s34 · Cited by 60
Folts, J. D., Schafer, A. I., Loscalzo, J., Willerson, J. T., & Muller, J. E. (1999) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(98)00601-9 · Cited by 59
Self-citationOosterga, M., Anthonio, R. L., de Kam, P., Kingma, J. H., Crijns, H. J. G. M., & van Gilst, W. H. (1998) · The American Journal of Cardiology · doi:10.1016/s0002-9149(98)00153-2 · Cited by 56
Bolz, S., & Pohl, U. (1997) · Cardiovascular Research · doi:10.1016/s0008-6363(97)00197-1 · Cited by 55
Effects of acetylsalicylic acid on renal function in patients with chronic heart failure
Riegger, G. A. J., Kahles, H. W., Elsner, D., Kromer, E. P., & KOCHSIEK, K. (1991) · The American Journal of Medicine · doi:10.1016/s0002-9343(05)80007-5 · Cited by 48
Stampfer, M. J., Jakubowski, J. A., Deykin, D., Schafer, A. I., Willett, W. C., & Hennekens, C. H. (1986) · The American Journal of Medicine · doi:10.1016/0002-9343(86)90289-5 · Cited by 42
Nawarskas, J. J., & Spinler, S. A. (1998) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/j.1875-9114.1998.tb03933.x · Cited by 40
Overview of patency as an end point of thrombolytic therapy
Anderson, J. L. (1991) · The American Journal of Cardiology · doi:10.1016/0002-9149(91)90300-a · Cited by 36
Tijssen, J. G. P. (1998) · Neurology · doi:10.1212/wnl.51.3_suppl_3.s15 · Cited by 28
Cited by
Rothwell, P. M., Wilson, M., Elwin, C.-E., Norrving, B., Algra, A., Warlow, C. P., & Meade, T. W. (2010) · The Lancet · doi:10.1016/s0140-6736(10)61543-7 · Cited by 1,351
A Comprehensive Review of Non-Steroidal Anti-Inflammatory Drug Use in The Elderly
Wongrakpanich, S., Wongrakpanich, A., Melhado, K., & Rangaswami, J. (2018) · Aging and disease · doi:10.14336/ad.2017.0306 · Cited by 917
Clinical Research to Clinical Practice — Lost in Translation?
Lenfant, C. (2003) · New England Journal of Medicine · doi:10.1056/nejmsa035507 · Cited by 898
Flossmann, E., & Rothwell, P. M. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60747-8 · Cited by 820
Nanoparticle‐induced platelet aggregation and vascular thrombosis
Radomski, A., Jurasz, P., Alonso‐Escolano, D., Drews, M., Morandi, M., Malinski, T., & Radomski, M. W. (2005) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706386 · Cited by 636
Metadata
- Authors
- Awtry, E. H., & Loscalzo, J.
- Venue
- Circulation
- Published
- 2000-03-14
- Volume
- 101
- Issue
- 10
- Pages
- 1206-1218
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W4211207317
- Cited by
- 690
- References
- 107
- FWCI
- 16.22
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.